HK-001

· Everfront Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HK-001, covering 2025-02-26 to 2025-02-26. Get the full timeline:

Most recent: Clinical Trial Update: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers [Phase 1]